Markel Group Inc. filings document the financial reporting, governance, and capital-structure disclosures of a diversified holding company centered on specialty insurance. Its regulatory record includes 8-K reports for annual and quarterly results, Regulation FD materials such as shareholder letters, leadership and compensation changes, and reporting changes tied to business re-segmentation.
Proxy filings describe board matters, executive compensation, shareholder voting items, and equity-award disclosures. Other filings address registered securities and plan-interest matters, including Costa Farms LLC 401(k) Plan disclosures, while preserving Markel Group’s continuing reporting obligations for its common shares.
Markel Group executive Wilson Simon reported both a stock sale and an equity award. On February 26, 2026, he completed an open-market sale of 100 shares of Markel Group common stock at a price of $2,079.4848 per share, leaving him with 2,396.7456 directly owned shares.
On February 24, 2026, he received a grant of 868.117 restricted stock units under the MKL 2024 Equity Incentive Compensation Plan at no purchase price. According to the award terms, 629.914 RSUs are scheduled to vest on December 31, 2028, and 238.203 RSUs are scheduled to vest on February 24, 2029, subject to applicable conditions.
Markel Group Inc. furnished its 2025 shareholder letter, outlining another year of solid growth and long-term compounding. Operating revenues reached $15,513 million in 2025 versus $14,814 million in 2024, while operating income was $3,195 million and adjusted operating income rose to $2,304 million.
The letter highlights a 12% increase in intrinsic value per share in 2025 and strong multi‑year compound growth. Insurance delivered a 94% combined ratio, with international operations achieving an 83% combined ratio and 14% written premium growth, and reserve redundancies of $484 million reinforcing balance sheet strength.
Financials revenue grew to $737 million with higher adjusted operating income, Industrials produced $3.9 billion of revenue, and Consumer and Other revenues rose to $1.4 billion. Markel generated a 10.5% public equity return, repurchased 223,000 shares at an average $1,894, redeemed $600 million of preferred stock, and ended 2025 with shareholders’ equity of $18,598 million and invested assets of $37,439 million.
Markel Group Inc. reports 2025 operating revenues of $15,513 million and adjusted operating income of $2,304 million, supported by a diversified mix of insurance, industrial, financial, and consumer businesses. Shareholders' equity reached $18,598 million, with a debt-to-capital ratio of 19%.
The company emphasizes long-term capital compounding, citing five-year compound annual growth of 16% in its closing stock price and 15% in intrinsic value per share. Markel Insurance remains the cornerstone, generating $9,353 million of operating revenues with a 95% combined ratio and a five-year average annual return on equity of 13%.
Invested assets totaled $37,439 million, including $13,004 million of equity securities and $18,827 million of insurance float. Management highlights a culture of decentralized leadership guided by “The Markel Style,” while outlining extensive risk factors around equity concentration, catastrophe exposure, reserving uncertainty, reinsurance credit risk, competition, regulation, liquidity, and acquisition integration.
Markel Group Inc. is reshaping its leadership team, executive pay, and shareholder rights. Simon Wilson and Andrew Crowley have been promoted to Executive Vice Presidents overseeing insurance and non‑insurance operations, while longtime executive Mike Heaton is departing following a mutually agreed separation date in March 2026.
The board also approved higher base salaries and larger equity and cash incentive targets for several top executives, including CEO Tom Gayner, with most 2026 equity awards tied to multi‑year performance and subject to long vesting and holding requirements. In addition, amended bylaws now allow shareholders owning at least 25% of voting power for one year to request special meetings, expanding shareholder rights.
MARKEL GROUP INC. executive Wilson Simon, CEO of Markel Insurance, reported a Form 4 transaction involving company common stock. On February 17, 2026, he disposed of 47 shares of common stock at $2,084.46 per share as a tax-withholding disposition, meaning shares were surrendered to cover tax obligations rather than sold in an open-market trade. Following this transaction, his directly held stake stands at 1,628.6286 shares of Markel Group common stock.
Markel Group Inc. filed a Form 13F holdings report showing a total reported portfolio value of $12,544,358,274 across 205 positions. The filing lists 1 other included manager, Markel-Gayner Asset Management LLC. The report was signed by Thomas S. Gayner, Chief Executive Officer, on 02-06-2026.
Markel Group Inc. filed a current report stating that it issued a press release announcing its 2025 annual financial results. The company notes that this press release, dated February 4, 2026, is provided as an exhibit to the report for investors and the public to review.
Markel Group Inc. Chief Financial Officer Brian J. Costanzo reported acquiring additional common stock through an employee stock purchase plan. On December 31, 2025, he acquired 2.184 shares of Markel Group common stock at a price of $1,602.62 per share in a transaction classified as code J, with a footnote stating the shares were acquired under the qualified component of the MKL 2020 Employee Stock Purchase Plan in a transaction exempt under Exchange Act Rule 16b-3(c).
Following this transaction, Costanzo beneficially owned 956.5426 shares of common stock in direct ownership form and 223.836 shares held indirectly through a 401(k) plan, based on the plan balance as of December 31, 2025.
Markel Group Inc. director Steven A. Markel reported multiple open-market sales of Markel Group common stock on December 11, 2025. The transactions, coded as sales, involved small blocks of shares at prices including $2,100 and $2,129.98 per share and were effected under a Rule 10b5-1 trading plan adopted on August 15, 2025. After these sales, he directly beneficially owned 60,368 shares, held 2,060.699 shares through a Markel 401(k) plan as of September 30, 2025, and 15,000 additional shares were held by his spouse, for which beneficial ownership is expressly disclaimed.
Steven A. Markel filed a notice of proposed sale of common shares under Rule 144. The notice covers 1,330 common shares to be sold through Fidelity Brokerage Services LLC on or about December 11, 2025, with an aggregate market value of $2,818,429.32. The issuer had 12,610,250 common shares outstanding. During the past three months, Markel sold 70 and 100 common shares on November 26, 2025 and November 28, 2025 for gross proceeds of $147,000.00 and $210,000.00.